News Center

Home page

Peak Report

News reports

Pharmaceutical companies to promote the production and sales of Chinese herbal pieces

Release time:

2022-12-13

walked into the traditional Chinese medicine decoction pieces workshop of Jinhua pharmaceutical company. the air was full of strong flavor of traditional Chinese medicine. the cooking machine "poop-poop " in the cooking room was steaming. the staff in charge of the care came to check the production situation from time to time. In the washing room, the machinery and equipment have just been cleaned, waiting for the next batch of medicinal materials "patronage " , several employees cooperate with tacit understanding, skillfully put Chinese herbal medicine into packaging bags, weighing, sealing, packing and storing in the warehouse, waiting to be shipped to the market ...... This is the production of Chinese herbal medicine workshop normal.

In the past two years, the sales volume and production orders of Chinese herbal pieces of pharmaceutical companies have increased significantly. In order to ensure that all orders of Chinese herbal pieces can be completed with good quality and quantity, the front-line production workers are working at full capacity and working overtime to put into production. Due to space constraints, the Chinese herbal medicine workshop arranges up to three different varieties of Chinese medicine production at a time, interspersed with processing procedures such as cleaning, slicing, drying, sterilization, packaging and storage. The weekly business department of the workshop receives orders for production and scheduling. The production volume of 16-20 tons of Chinese herbal pieces should be completed in one month, reaching 90 tons in one month at most. The production workshop is busy with production. When the business and storage personnel are tight, the pharmaceutical company also organizes logistics personnel to help ensure the on-time delivery of orders.

"The implementation of the new policy of no more than 25% of Chinese herbal pieces has not only reduced the medical expenses of patients, effectively guided the masses to choose more Chinese medicine services, but also promoted the concept of high quality and good price of Chinese herbal pieces. Wu Weisheng, general manager of " Pharmaceutical Company, said that on the 28th of June 1# this year, the "Implementation Opinions of Zhejiang Medical Security Bureau on Supporting the Inheritance and Innovation of Traditional Chinese Medicine" was formally implemented. Zhejiang Province required public medical institutions to strictly implement the bonus policy of increasing 25% sales according to the actual purchase price. The prices of Chinese herbal pieces in many places have dropped significantly, medical institutions pay more attention to the quality of drugs when purchasing Chinese herbal pieces. With the help of this policy change, pharmaceutical companies further optimize the suppliers of raw medicinal materials and purchase raw materials on the premise of high quality and good price. Every process in the production process is very strict. In addition to the on-site follow-up by the quality inspection personnel, each batch of traditional Chinese medicine produced is sent to the quality inspection center for inspection to ensure the quality of each batch of medicinal materials and give full play to the curative effect of medicinal materials. so that people can use conscience medicine, rest assured medicine and fine medicine anytime and anywhere. The high quality of products naturally drives the increase of sales volume. The output of Chinese herbal medicine workshop has also increased significantly compared with the same period last year, and the market development has also reached a new high. This year, the pharmaceutical company successfully broke through from

suppliers of traditional Chinese medicine and became one of 2 suppliers of Jinhua Hospital of Traditional Chinese Medicine. The sales volume directly doubled from the original small proportion. 4# Starting in 39, the bid for the distribution right of Chinese herbal pieces of medical institutions in Pan 'an County was won. , distribution bidding for township hospitals in Wucheng District, the pharmaceutical company ranked first in the distribution enterprise in terms of qualification, service and sample quality. The sales volume of Chinese herbal pieces in a hospital in Yongkang has also doubled this year. The relevant person in charge of the Chinese medicine department of the pharmaceutical company said that the increase in production capacity and sales, with sales, not only ensures product quality, but also reduces procurement costs to a certain extent, forming a healthy development of production and sales. Wu Weisheng said that at present, the traditional Chinese medicine decoction pieces business of pharmaceutical companies includes production and trade, with both self-operated varieties and OEM products. Next, pharmaceutical companies will also give full play to their advantages, adjust the industrial structure, and make every effort to promote the production and sales of Chinese herbal pieces according to the actual production of enterprises.

(Reporter

Ni Yingzhen)

More information

The company was rated as an advanced unit of the city's focus on talent and love talent.

News from our newspaper On December 11, the Talent Work Leading Group of the Jinhua Municipal Committee of the Communist Party of China commended the advanced units of Jinhua City that value talents and love talents. 36 units including Jianfeng Group won this honor. The selection of advanced units that value talents and love talents is a measure taken by the Jinhua Municipal Party Committee to further create a good atmosphere of focusing on talents and loving talents, fully respect and make good use of the first resource of talents, serve innovation to drive development, and implement the development strategy of strengthening the province with talents and innovation. The enterprises and institutions that have won this honorary title have always regarded talents as the fundamental driving force for development for a long time, regarded the investment of talents as the most effective investment, and integrated the love of talents into the unit culture. Remarkable achievements have been made in gathering talents, achieving talents, transforming and upgrading, and accelerating development. The Jinhua Municipal Party Committee requires the majority of employers to learn from advanced units, vigorously promote the trend of focusing on talents and loving talents, remove the obstacles to the talent development system and mechanism, and in accordance with the requirements of "walking in the forefront and jointly building Jinhua", in order to promote the construction of a modern metropolitan area and accelerate the construction of the province An important growth pole for high-quality development provides talent support and intellectual guarantee. (this newspaper reporter)

2020

07-31

The company was rated as an advanced unit of the city's focus on talent and love talent.

2020

07-30

Peak Pharmaceutical Becomes National Intellectual Property Demonstration Enterprise

Just one year after it was identified as a national intellectual property advantage enterprise in 2016, "Zhejiang Jianfeng Pharmaceutical Co., Ltd." appeared in the list of national intellectual property demonstration enterprises in 2017 recently announced by the State Intellectual Property Office. As a result, Jianfeng Pharmaceutical has become the first and only national intellectual property demonstration enterprise in Jinhua City. On December 12, the State Intellectual Property Office issued a notice to announce the list of national intellectual property demonstration enterprises and advantageous enterprises in 2017. After the enterprise declaration, the recommendation of the provincial and municipal bureaus, the review of the national bureau, and the public announcement, 182 national intellectual property demonstration enterprises and 816 national intellectual property advantage enterprises have been identified. Including Jianfeng Pharmaceutical, Zhejiang Province has been identified as only 15 national intellectual property demonstration enterprises. With the continuous development of enterprises in recent years, Jianfeng Pharmaceutical has set up a special working organization to cultivate and improve the intellectual property ability from the aspects of strategic management, creation, operation and protection of intellectual property rights. It has successively compiled and implemented 27 procedural documents and 36 forms such as "Intellectual Property Management Manual", "Intellectual Property Reward and Punishment System" and "Trade Secret Management System, and timely according to the policy, the current situation of the enterprise to revise, in order to ensure the compliance and effectiveness of the operation of the system. In 2012 and 2013, Jianfeng Pharmaceutical was successively rated as a patent demonstration enterprise in Jinhua City and Zhejiang Province; in 2013, it won the third prize of Jinhua Patent Implementation Award; in 2016, it passed the certification of intellectual property management system and was identified as a national intellectual property advantage enterprise. Currently, Peak Pharmaceuticals has

2020

07-31

Jianfeng Pharmaceutical Approved to Set up Provincial Research Institute

A few days ago, the relevant departments of Zhejiang Province approved the establishment of the provincial research institute of the peak pharmaceutical company. This is another honor won by Jianfeng Pharmaceutical in the field of independent research and development and scientific and technological innovation after the national postdoctoral research workstation and Zhejiang academician expert workstation. The provincial enterprise research institute is a high-level R & D institution led by the Provincial Department of Science and Technology, jointly recognized by the Provincial Economic and Information Commission and the Provincial Development and Reform Commission. As an important part of the national technological innovation system, the Enterprise Research Institute is the core force of the innovation-driven development of Jianfeng Pharmaceutical, which reflects the ability of Jianfeng Pharmaceutical to set up higher-level and higher-level R & D institutions on its own. the ability to gather and integrate innovation elements, organize scientific and technological innovation, support the sustainable development of enterprises, and lead the technological progress of the industry. As a pharmaceutical enterprise, scientific and technological innovation is the eternal theme of enterprise development, and talent is the key to scientific and technological innovation. Over the years, Jianfeng Pharmaceutical has not only focused on cultivating its own scientific research talents, but also established close cooperative relations with well-known universities and scientific research institutions such as China Pharmaceutical University, Shenyang Pharmaceutical University, Sichuan Antibiotic Industry Research Institute, and also focused on introducing top think tanks. In 2011, Professor Liu Jiajian and his team from Sichuan Institute of Antibiotic Industry were introduced, focusing on the technical research of key intermediates of methoxy cephalosporin. In 2013, Professor Shan Weiguang and his scientific research team from Zhejiang University of Technology were introduced to carry out research on preparation technology. In 2015, Professor Wang Guangji, academician of the Chinese Academy of Engineering, was hired as the chief scientist to organize the research on the anti-drug resistance mechanism of national class I new drugs by intracellular pharmacokinetics. In 2017 with Shanghai antibody

2020

07-31

The company elects a new board of directors and the board of supervisors to appoint a new management team

On November 16, the company held the first extraordinary general meeting of shareholders in 2017, which deliberated and passed the proposal on the expiration of the term of the board of directors and the proposal on the expiration of the term of the board of supervisors, and elected a new board of directors and the board of supervisors. The meeting used a combination of on-site registered voting and online voting to vote on director candidates one by one, and elected Jiang Xiaomeng, Du Zihong, Yu Jianhong, Huang Sujian, Liu Bo, Zhang Guoping, Huang Conyun, Sun Hongbin, and Shi Ximin as the company's tenth board of directors. Directors, of which Huang Conyun, Sun Hongbin, and Shi Ximin are independent directors. The meeting used a combination of on-site registered voting and online voting to vote on supervisor candidates one by one, and elected Chen Tianci, Lu Ruimei, and Shi Fu as supervisors of the company's ninth board of supervisors. Prior to this, the company's trade union held an enlarged meeting of the trade union committee to elect Qin Xuping and Jin Huazhong as employee representative supervisors of the ninth board of supervisors. On the same day, the company's tenth board of directors held its first meeting and elected Jiang Xiaomeng as the chairman of the tenth board of directors. Jiang Xiaomeng, Du Zihong, Huang Sujian, Sun Hongbin and Shi Ximin were elected as members of the Strategy Committee of the 10th Board of Directors, and Jiang Xiaomeng was the chairman of the Strategy Committee. Shi Ximin, Huang Conyun and Jiang Xiaomeng were elected as members of the audit committee of the 10th board of directors, and Shi Ximin was the chairman. Sun Hongbin, Huang Conyun and Jiang Xiaomeng were elected as members of the nomination committee of the 10th board of directors, and Sun Hongbin was the chairman. Huang Cong Yun, Shi Ximin and Du Zihong were elected as members of the remuneration and assessment committee of the 10th board of directors, and Huang Cong Yun was the chairman. The board of directors appointed Yu Jianhong as the general manager of the company and appointed Huang Jinlong.

2020

07-31

Peak natural products pollution control results by the industry attention

As a leader in China's plant extracts industry, Tianjin Jianfeng Natural Products Company has achieved fruitful results in technological innovation. On October 26 and 27, at the 2017 Forum on improving the international competitiveness of China's plant extract industry held in Handan City, Hebei Province, Liu Dan, general manager of the company, delivered a speech entitled "prevention and control of water pollution in the field of plant extraction", introducing the successful experience of sewage treatment in the past five years, which was widely concerned by the participants. In recent years, environmental protection and ecology have become hot words for the development of enterprises and society. Due to the particularity of the plant extraction industry, pollution control in this industry has different characteristics and requirements from ordinary production enterprises. For example, sewage presents higher chroma, extremely low PH value, more suspended solids, high salinity, high concentration of COD, and different sewage water quality of different products. As the earliest enterprise producing opc grape seed extract in China, Natural Products Company has always attached great importance to the pollution control of plant extraction. For example, in the sewage treatment upgrading project implemented in 2016, ozone oxidation and biochemical methods were adopted to remove the remaining organic pollutants, increasing the sewage treatment capacity from 200 cubic meters per day to 500 cubic meters. The latest anaerobic sewage treatment technology is adopted, the COD emission value of the outlet is reduced to 60 mg per liter, which is far lower than the national first-class emission standard of 100 mg per liter. The new system adopts advanced oxidation reaction tower, ozonation method, field energy reactor and sludge adsorption reflux technology, which can quickly and efficiently treat organic pollutants with strong chemical stability without adding any chemicals.

2020

07-31

< 1...39 40 41...61 > 跳转到页